PERSANTINE 10 mg/2 ml, solution for injection, ampoule 10 ampoules of 2 ml
Active ingredients: Dipyridamole
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only, hospital use
Solution for injection10 ampoules of 2 mlintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- PERSANTINE 10 mg/2 mL, solution injectable, ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 May 2003
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68572748CIP75623409CIP133400956234097Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIPYRIDAMOLEsolution | 10 mg · une ampoule de 2 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.